{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:38:51Z","timestamp":1794566331425,"version":"4.9.1"},"reference-count":116,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Res Med Sci"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jrms.jrms_777_20","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T01:22:04Z","timestamp":1606267324000},"page":"109","source":"Crossref","is-referenced-by-count":23,"title":["N-acetylcysteine and coronavirus disease 2019: May it work as a beneficial preventive and adjuvant therapy? A comprehensive review study"],"prefix":"10.4103","volume":"25","author":[{"given":"Azadeh","family":"Goodarzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmolsadat","family":"Atefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Behrangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Mozafarpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnoosh","family":"Seirafianpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Peighambari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1735-1995.301551-1","unstructured":"Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment Coronavirus (COVID-19). Treasure Island, FL: StatPearls Publishing LLC; 2020."},{"key":"key-10.4103\/1735-1995.301551-2","unstructured":"McIntosh K, Hirsch MS, Bloom A. Coronavirus Disease 2019 (COVID-19). 2020, www.uptodate.com."},{"key":"key-10.4103\/1735-1995.301551-3","unstructured":"Cennimo DJ, Bronze MS. Coronavirus Disease 2019 (COVID-19) Treatment and Management. Medscape Updated; 2020."},{"key":"key-10.4103\/1735-1995.301551-4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/pathogens9030186","article-title":"Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks","author":"Ashour","year":"2020","journal-title":"Pathogens"},{"key":"key-10.4103\/1735-1995.301551-5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1473-3099(20)30195-X","article-title":"Real estimates of mortality following COVID-19 infection","author":"Baud","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"key-10.4103\/1735-1995.301551-6","first-page":"2012","article-title":"Novel coronavirus 2019-nCoV: Prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV","author":"Meo","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key-10.4103\/1735-1995.301551-7","doi-asserted-by":"crossref","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/1735-1995.301551-8","first-page":"536","article-title":"The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2","author":"Gorbalenya","year":"2020","journal-title":"Nat Microbiol"},{"key":"key-10.4103\/1735-1995.301551-9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"key-10.4103\/1735-1995.301551-10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"key-10.4103\/1735-1995.301551-11","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"key-10.4103\/1735-1995.301551-12","unstructured":"Ershad M, Vearrier D. N Acetylcysteine. Treasure Island, FL: StatPearls Publishing; 2019."},{"key":"key-10.4103\/1735-1995.301551-13","first-page":"140","article-title":"The application of N-acetylcysteine in optimization of specific pharmacological therapies","author":"Ho\u0142y\u0144ska-Iwan","year":"2017","journal-title":"Pol Merkur Lekarski"},{"key":"key-10.4103\/1735-1995.301551-14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5152\/eajm.2013.35","article-title":"The effects of erdosteine and N-acetylcysteine on apoptotic and antiapoptotic markers in pulmonary epithelial cells in sepsis","author":"Demiralay","year":"2013","journal-title":"Eurasian J Med"},{"key":"key-10.4103\/1735-1995.301551-15","doi-asserted-by":"crossref","first-page":"e32503","DOI":"10.1371\/journal.pone.0032503","article-title":"N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity","author":"Sun","year":"2012","journal-title":"PLoS One"},{"key":"key-10.4103\/1735-1995.301551-16","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.3892\/mmr.2017.7442","article-title":"N-acetylcysteine induces apoptosis via the mitochondria-dependent pathway but not via endoplasmic reticulum stress in H9c2 cells","author":"Liu","year":"2017","journal-title":"Mol Med Rep"},{"key":"key-10.4103\/1735-1995.301551-17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.taap.2018.04.010","article-title":"N-acetylcysteine transforms necrosis into apoptosis and affords tailored protection from cisplatin cytotoxicity","author":"Sancho-Mart\u00ednez","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"key-10.4103\/1735-1995.301551-18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"key-10.4103\/1735-1995.301551-19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"key-10.4103\/1735-1995.301551-20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"key-10.4103\/1735-1995.301551-21","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1735-1995.301551-22","doi-asserted-by":"crossref","unstructured":"Gorbalenya AE. Severe Acute Respiratory Syndrome-Related Coronavirus-The Species and its Viruses, a Statement of the Coronavirus Study Group. BioRxiv; 2020.","DOI":"10.1101\/2020.02.07.937862"},{"key":"key-10.4103\/1735-1995.301551-23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"key-10.4103\/1735-1995.301551-24","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S0140-6736(20)30558-4","article-title":"Comorbidities and multi-organ injuries in the treatment of COVID-19","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"key-10.4103\/1735-1995.301551-25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"key-10.4103\/1735-1995.301551-26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1067\/mjd.2002.118557","article-title":"Toxic epidermal necrolysis treated with N-acetylcysteine","author":"V\u00e9lez","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/1735-1995.301551-27","first-page":"1","article-title":"N-acetylcysteine in the effective management of TEN-associated severe skin lesions","author":"Hasan","year":"2019","journal-title":"Adv Pharmacol Pharm"},{"key":"key-10.4103\/1735-1995.301551-28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5144\/0256-4947.2019.251","article-title":"Safety and efficacy of adding intravenous N-acetylcysteine to parenteral L-alanyl-L-glutamine in hospitalized patients undergoing surgery of the colon: A randomized controlled trial","author":"Hamamsy","year":"2019","journal-title":"Ann Saudi Med","ISSN":"https:\/\/id.crossref.org\/issn\/0256-4947","issn-type":"print"},{"key":"key-10.4103\/1735-1995.301551-29","first-page":"265","article-title":"N-acetylcysteine: Multiple clinical applications","author":"Millea","year":"2009","journal-title":"Am Fam Physician"},{"key":"key-10.4103\/1735-1995.301551-30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2013.09.006","article-title":"Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits","author":"Rushworth","year":"2014","journal-title":"Pharmacol Ther"},{"key":"key-10.4103\/1735-1995.301551-31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.lfs.2016.03.003","article-title":"A minireview on N-acetylcysteine: An old drug with new approaches","author":"Dhouib","year":"2016","journal-title":"Life Sci"},{"key":"key-10.4103\/1735-1995.301551-32","first-page":"11","article-title":"A review on various uses of N-acetyl cysteine","author":"Mokhtari","year":"2017","journal-title":"Cell J"},{"key":"key-10.4103\/1735-1995.301551-33","doi-asserted-by":"crossref","first-page":"2835787","DOI":"10.1155\/2018\/2835787","article-title":"Biological activities and potential oral applications of N-acetylcysteine: Progress and prospects","author":"Pei","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"key-10.4103\/1735-1995.301551-34","first-page":"817849","article-title":"N-acetylcysteine for polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled clinical trials","author":"Thakker","year":"2015","journal-title":"Obstet Gynecol Int"},{"key":"key-10.4103\/1735-1995.301551-35","doi-asserted-by":"crossref","first-page":"656","DOI":"10.9738\/INTSURG-D-14-00227.1","article-title":"Topical N-acetylcysteine improves wound healing comparable to dexpanthenol: An experimental study","author":"Oguz","year":"2015","journal-title":"Int Surg"},{"key":"key-10.4103\/1735-1995.301551-36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.5021\/ad.2015.27.4.450","article-title":"Effects of topical N-acetylcysteine on skin hydration\/transepidermal water loss in healthy volunteers and atopic dermatitis patients","author":"Nakai","year":"2015","journal-title":"Ann Dermatol"},{"key":"key-10.4103\/1735-1995.301551-37","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.jdermsci.2017.02.094","article-title":"Topical N-acetylcysteine can restore skin barrier function in healthy volunteers and atopic dermatitis patients","author":"Nakai","year":"2017","journal-title":"J Dermatol Sci"},{"key":"key-10.4103\/1735-1995.301551-38","first-page":"201","article-title":"Clinical applications of N-acetylcysteine in dermatology","author":"Zargari","year":"2010","journal-title":"J Dermatol Cosmet"},{"key":"key-10.4103\/1735-1995.301551-39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1179\/1351000215Y.0000000015","article-title":"Oxidative stress and antioxidant strategies in dermatology","author":"Baek","year":"2016","journal-title":"Redox Rep"},{"key":"key-10.4103\/1735-1995.301551-40","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4103\/ijdvl.IJDVL_33_18","article-title":"N-acetylcysteine in dermatology","author":"Adil","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/1735-1995.301551-41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/antiox8050111","article-title":"Medical and dietary uses of N-acetylcysteine","author":"\u0160alamon","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"key-10.4103\/1735-1995.301551-42","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s40279-017-0677-3","article-title":"Performance and side effects of supplementation with n-acetylcysteine: A systematic review and meta-analysis","author":"Rhodes","year":"2017","journal-title":"Sports Med"},{"key":"key-10.4103\/1735-1995.301551-43","first-page":"20","article-title":"The potential uses of N-acetylcysteine in dermatology: A review","author":"Janeczek","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"key":"key-10.4103\/1735-1995.301551-44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/039463200702000215","article-title":"N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection","author":"Garozzo","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"key-10.4103\/1735-1995.301551-45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bcp.2009.08.025","article-title":"N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus","author":"Geiler","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"key-10.4103\/1735-1995.301551-46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-5751-10-5","article-title":"N-acetylcysteine lacks universal inhibitory activity against influenza A viruses","author":"Garigliany","year":"2011","journal-title":"J Negat Results Biomed"},{"key":"key-10.4103\/1735-1995.301551-47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15586\/jcbmr.2016.13","article-title":"N-acetylcysteine: An old drug with variable anti-influenza properties","author":"Casanova","year":"2016","journal-title":"J Controvers Biomed Res"},{"key":"key-10.4103\/1735-1995.301551-48","doi-asserted-by":"crossref","first-page":"e0189167","DOI":"10.1371\/journal.pone.0189167","article-title":"N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation","author":"Gao","year":"2017","journal-title":"PLoS One"},{"key":"key-10.4103\/1735-1995.301551-49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/aid.1992.8.209","article-title":"N-acetylcysteine: A new approach to anti-HIV therapy","author":"Roederer","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key-10.4103\/1735-1995.301551-50","first-page":"915","article-title":"N-acetylcysteine replenishes glutathione in HIV infection","author":"De","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"key-10.4103\/1735-1995.301551-51","first-page":"457","article-title":"Effect of N-acetylcysteine (NAC) treatment on HIV-1 infection: A double-blind placebo-controlled trial","author":"Akerlund","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.4103\/1735-1995.301551-52","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.3748\/wjg.v9.i12.2698","article-title":"N-acetyl cysteine therapy in acute viral hepatitis","author":"Gunduz","year":"2003","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/1735-1995.301551-53","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13054-018-2002-4","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: Lessons learned from acute respiratory distress syndrome?","author":"Marchioni","year":"2018","journal-title":"Crit Care"},{"key":"key-10.4103\/1735-1995.301551-54","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/crj.12631","article-title":"Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis","author":"Qiu","year":"2018","journal-title":"Clin Respir J"},{"key":"key-10.4103\/1735-1995.301551-55","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.chest.2015.11.013","article-title":"Drug treatment of idiopathic pulmonary fibrosis: Systematic review and network meta-analysis","author":"Canestaro","year":"2016","journal-title":"Chest"},{"key":"key-10.4103\/1735-1995.301551-56","first-page":"147","article-title":"N-acetylcysteine inhibits TNF-alpha, sTNFR, and TGF-beta1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro","author":"Cu","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key-10.4103\/1735-1995.301551-57","first-page":"636","article-title":"Efficacy of antioxidant in idiopathic pulmonary fibrosis: A systematic review and meta-analysis","author":"Kandhare","year":"2016","journal-title":"EXCLI J"},{"key":"key-10.4103\/1735-1995.301551-58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pupt.2016.07.009","article-title":"Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis","author":"Rogliani","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"key":"key-10.4103\/1735-1995.301551-59","doi-asserted-by":"crossref","first-page":"e3629","DOI":"10.1097\/MD.0000000000003629","article-title":"Efficacy of N-acetylcysteine in idiopathic pulmonary fibrosis: A systematic review and meta-analysis","author":"Sun","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key-10.4103\/1735-1995.301551-60","first-page":"S5","article-title":"Systematic review and network meta-analysis of idiopathic pulmonary fibrosis treatments","author":"Fleetwood","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"key-10.4103\/1735-1995.301551-61","first-page":"5170638","article-title":"Chinese herbal medicines compared with N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review of randomized controlled trials","author":"Guo","year":"2019","journal-title":"Evid Based Complement Altern Med"},{"key":"key-10.4103\/1735-1995.301551-62","first-page":"802","article-title":"Efficacy and safety of N-acetylcysteine therapy for idiopathic pulmonary fibrosis: An updated systematic review and meta-analysis","author":"Feng","year":"2019","journal-title":"Exp Ther Med"},{"key":"key-10.4103\/1735-1995.301551-63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1753465812437563","article-title":"N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease","author":"Sadowska","year":"2012","journal-title":"Ther Adv Respir Dis"},{"key":"key-10.4103\/1735-1995.301551-64","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/15412555.2014.898040","article-title":"Oxidative stress and respiratory system: Pharmacological and clinical reappraisal of N-acetylcysteine","author":"Santus","year":"2014","journal-title":"COPD"},{"key":"key-10.4103\/1735-1995.301551-65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0149-2918(00)88479-9","article-title":"Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: A meta-analysis of published double-blind, placebo-controlled clinical trials","author":"Grandjean","year":"2000","journal-title":"Clin Ther"},{"key":"key-10.4103\/1735-1995.301551-66","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1399-3003.2000.16b12.x","article-title":"The effect of oral N-acetylcysteine in chronic bronchitis: A quantitative systematic review","author":"Stey","year":"2000","journal-title":"Eur Respir J"},{"key":"key-10.4103\/1735-1995.301551-67","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2147\/COPD.S51057","article-title":"Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease","author":"Tse","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"key-10.4103\/1735-1995.301551-68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1586\/17476348.2016.1121105","article-title":"Oxidation pathway and exacerbations in COPD: The role of NAC","author":"Matera","year":"2016","journal-title":"Expert Rev Respir Med"},{"key":"key-10.4103\/1735-1995.301551-69","first-page":"351","article-title":"Effect of high\/low dose N-acetylcysteine on chronic obstructive pulmonary disease: A systematic review and meta-analysis","author":"Shen","year":"2014","journal-title":"COPD"},{"key":"key-10.4103\/1735-1995.301551-70","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.hrtlng.2016.12.004","article-title":"The effect of N-acetylcysteine on exacerbations of chronic obstructive pulmonary disease: A meta-analysis and systematic review","author":"Fowdar","year":"2017","journal-title":"Heart Lung"},{"key":"key-10.4103\/1735-1995.301551-71","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/17476348.2018.1495562","article-title":"Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease","author":"Calzetta","year":"2018","journal-title":"Expert Rev Respir Med"},{"key":"key-10.4103\/1735-1995.301551-72","first-page":"PA2958","article-title":"N-acetylcysteine and mortality in hospitalized pulmonary tuberculosis infection","author":"Jeeraaumponwat","year":"2019","journal-title":"Eur Respir Soc"},{"key":"key-10.4103\/1735-1995.301551-73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/jof4040117","article-title":"Nebulised N-acetylcysteine for unresponsive bronchial obstruction in allergic brochopulmonary aspergillosis: A case series and review of the literature","author":"Otu","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"key-10.4103\/1735-1995.301551-74","first-page":"19","article-title":"Safety and efficacy of N-acetyl-cysteine for prophylaxis of ventilator-associated pneumonia: A randomized, double blind, placebo-controlled clinical trial","author":"Sharafkhah","year":"2018","journal-title":"Med Gas Res","ISSN":"https:\/\/id.crossref.org\/issn\/2045-9912","issn-type":"print"},{"key":"key-10.4103\/1735-1995.301551-75","doi-asserted-by":"crossref","first-page":"e13087","DOI":"10.1097\/MD.0000000000013087","article-title":"N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: A randomized controlled trial","author":"Zhang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"key-10.4103\/1735-1995.301551-76","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/0960327107083452","article-title":"Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: Evidence for underlying toxicological mechanisms","author":"Soltan-Sharifi","year":"2007","journal-title":"Hum Exp Toxicol"},{"key":"key-10.4103\/1735-1995.301551-77","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13054-017-1809-8","article-title":"A systematic review of diagnostic methods to differentiate acute lung injury\/acute respiratory distress syndrome from cardiogenic pulmonary edema","author":"Komiya","year":"2017","journal-title":"Crit Care"},{"key":"key-10.4103\/1735-1995.301551-78","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3892\/etm.2017.4891","article-title":"Effects of N-acetylcysteine treatment in acute respiratory distress syndrome: A meta-analysis","author":"Zhang","year":"2017","journal-title":"Exp Ther Med"},{"key":"key-10.4103\/1735-1995.301551-79","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.2017.21907","article-title":"Acute respiratory distress syndrome: Advances in diagnosis and treatment","author":"Fan","year":"2018","journal-title":"JAMA"},{"key":"key-10.4103\/1735-1995.301551-80","first-page":"F1000 Faculty Rev","article-title":"Recent advances in understanding and treating acute respiratory distress syndrome","author":"Nanchal","year":"1000","journal-title":"F"},{"key":"key-10.4103\/1735-1995.301551-81","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4103\/0366-6999.231520","article-title":"Pharmacotherapy for adult patients with acute respiratory distress syndrome","author":"Yin","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"key-10.4103\/1735-1995.301551-82","first-page":"1","article-title":"N-acetylcysteine for adults with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials","author":"Lu","year":"2019","journal-title":"Hong Kong J Emerg Med"},{"key":"key-10.4103\/1735-1995.301551-83","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4187\/respcare.06965","article-title":"Immunonutrition for adults with ARDS: Results from a cochrane systematic review and meta-analysis","author":"Dushianthan","year":"2020","journal-title":"Respir Care"},{"key":"key-10.4103\/1735-1995.301551-84","first-page":"21","article-title":"The use of N-acetylcysteine in intensive care","author":"Atkinson","year":"2002","journal-title":"Crit Care Resusc"},{"key":"key-10.4103\/1735-1995.301551-85","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/cc6830","article-title":"Clinical review: Airway hygiene in the intensive care unit","author":"Jelic","year":"2008","journal-title":"Crit Care"},{"key":"key-10.4103\/1735-1995.301551-86","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/cc11316","article-title":"Antioxidant micronutrients in the critically ill: A systematic review and meta-analysis","author":"Manzanares","year":"2012","journal-title":"Crit Care"},{"key":"key-10.4103\/1735-1995.301551-87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/2008-2231-22-57","article-title":"The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients","author":"Najafi","year":"2014","journal-title":"Daru"},{"key":"key-10.4103\/1735-1995.301551-88","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/cc2887","article-title":"N-acetylcysteine in clinical sepsis: A difficult marriage","author":"Spapen","year":"2004","journal-title":"Crit Care"},{"key":"key-10.4103\/1735-1995.301551-89","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4037\/ccn2013699","article-title":"N-acetylcysteine for sepsis and systemic inflammatory response in adults","author":"Visvanathan","year":"2013","journal-title":"Crit Care Nurse"},{"key":"key-10.4103\/1735-1995.301551-90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/0885066617696850","article-title":"N-acetylcysteine's role in sepsis and potential benefit in patients with microcirculatory derangements","author":"Chertoff","year":"2018","journal-title":"J Intensive Care Med"},{"key":"key-10.4103\/1735-1995.301551-91","first-page":"CD006616","article-title":"N-acetylcysteine for sepsis and systemic inflammatory response in adults","author":"Szakmany","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/1735-1995.301551-92","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40256-018-0275-2","article-title":"A systematic review on the protective effect of N-acetyl cysteine against diabetes-associated cardiovascular complications","author":"Dludla","year":"2018","journal-title":"Am J Cardiovasc Drugs"},{"key":"key-10.4103\/1735-1995.301551-93","doi-asserted-by":"crossref","first-page":"104332","DOI":"10.1016\/j.phrs.2019.104332","article-title":"The beneficial effects of N-acetyl cysteine (NAC) against obesity associated complications: A systematic review of pre-clinical studies","author":"Dludla","year":"2019","journal-title":"Pharmacol Res"},{"key":"key-10.4103\/1735-1995.301551-94","doi-asserted-by":"crossref","first-page":"e0213862","DOI":"10.1371\/journal.pone.0213862","article-title":"N-acetylcysteine use among patients undergoing cardiac surgery: A systematic review and meta-analysis of randomized trials","author":"Pereira","year":"2019","journal-title":"PLoS One"},{"key":"key-10.4103\/1735-1995.301551-95","first-page":"PI13","article-title":"The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: A placebo-controlled, randomized, cross-over study","author":"Renke","year":"2010","journal-title":"Med Sci Monit"},{"key":"key-10.4103\/1735-1995.301551-96","first-page":"5","article-title":"Comparison of N-acetylcysteine and angiotensin converting enzyme inhibitors in blood pressure regulation in hypertensive patients","author":"Khaledifar","year":"2015","journal-title":"ARYA Atheroscler"},{"key":"key-10.4103\/1735-1995.301551-97","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1515\/JBCPP.2006.17.4.245","article-title":"The role of N-acetylcysteine treatment on anti-oxidative status in patients with Type II diabetes mellitus","author":"Ozkilic","year":"2006","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"key-10.4103\/1735-1995.301551-98","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12872-015-0076-3","article-title":"N-acetyl cysteine improves the diabetic cardiac function: Possible role of fibrosis inhibition","author":"Liu","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"key-10.4103\/1735-1995.301551-99","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s11255-018-1814-0","article-title":"Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: A network meta-analysis from randomized trials","author":"Ma","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"key-10.4103\/1735-1995.301551-100","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/bcp.12880","article-title":"N-acetylcysteine for non-paracetamol drug-induced liver injury: A systematic review","author":"Chughlay","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/1735-1995.301551-101","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5811\/westjem.2012.4.6885","article-title":"Oral and intravenous acetylcysteine for treatment of acetaminophen toxicity: A systematic review and meta-analysis","author":"Green","year":"2013","journal-title":"West J Emerg Med"},{"key":"key-10.4103\/1735-1995.301551-102","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/thoraxjnl-2015-207245","article-title":"A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: Implications for the treatment of multidrug-resistant TB","author":"Kranzer","year":"2015","journal-title":"Thorax"},{"key":"key-10.4103\/1735-1995.301551-103","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3389\/fneur.2017.00744","article-title":"Systematic review of human and animal studies examining the efficacy and safety of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) in traumatic brain injury: Impact on neurofunctional outcome and biomarkers of oxidative stress and inflammation","author":"Bhatti","year":"2018","journal-title":"Front Neurol"},{"key":"key-10.4103\/1735-1995.301551-104","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/acps.12862","article-title":"N-acetylcysteine for major mental disorders: A systematic review and meta-analysis of randomized controlled trials","author":"Zheng","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"key-10.4103\/1735-1995.301551-105","first-page":"182","article-title":"Heparin\/N-acetylcysteine: An adjuvant in the management of burn inhalation injury: A study of different doses","author":"Elsharnouby","year":"2014","journal-title":"J Crit Care"},{"key":"key-10.4103\/1735-1995.301551-106","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2011.05.014","article-title":"N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar Type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)","author":"Mata","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"key-10.4103\/1735-1995.301551-107","first-page":"1","article-title":"N-acetyl-l-cystine (NAC) protects against H9N2 swine influenza virus-induced acute lung injury","author":"Zhang","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"key-10.4103\/1735-1995.301551-108","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.antiviral.2018.01.002","article-title":"The role of adjuvant immunomodulatory agents for treatment of severe influenza","author":"Hui","year":"2018","journal-title":"Antiviral Res"},{"key":"key-10.4103\/1735-1995.301551-109","unstructured":"Van Hecke O, Lee J. N-Acetylcysteine: A Rapid Review of Evidence for Effectiveness in Treating COVID-19. The Center of Evidence Based Medicine; 2020."},{"key":"key-10.4103\/1735-1995.301551-110","first-page":"101063","article-title":"Efficacy of glutathione therapy in relieving dyspnea associated with covid-19 pneumonia: A report of 2 cases","author":"Horowitz","year":"2020","journal-title":"Respir Med Case Rep J"},{"key":"key-10.4103\/1735-1995.301551-111","doi-asserted-by":"crossref","first-page":"109778","DOI":"10.1016\/j.mehy.2020.109778","article-title":"N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome","author":"Assimakopoulos","year":"2020","journal-title":"Med Hypotheses"},{"key":"key-10.4103\/1735-1995.301551-112","first-page":"e13733","article-title":"Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy.Dermatol Ther??","author":"Seirafianpour","year":"2020","journal-title":""},{"key":"key-10.4103\/1735-1995.301551-113","first-page":"e13986","article-title":"Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.Dermatol Ther?","author":"Seirafianpour","year":"2020","journal-title":""},{"key":"key-10.4103\/1735-1995.301551-114","first-page":"e13867","article-title":"Patients with specific skin disorders who are affected by COVID-19: What do experiences say about management strategies.A systematic review?","author":"Nobari","year":"2020","journal-title":"Dermatol Ther"},{"key":"key-10.4103\/1735-1995.301551-115","first-page":"290","article-title":"Comparison of long-pulsed alexandrite laser and topical tretinoin-ammonium lactate in axillary acanthosis nigricans: A case series of patients in a before-after trial","author":"Ehsani","year":"2016","journal-title":"Caspian J Intern Med"},{"key":"key-10.4103\/1735-1995.301551-116","first-page":"841","article-title":"Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review.Med J Islam Repub Iran","author":"Mohamadi","year":"2020","journal-title":""}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:50:09Z","timestamp":1786733409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.JRMS_777_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["301551"],"URL":"https:\/\/doi.org\/10.4103\/jrms.jrms_777_20","relation":{},"ISSN":["1735-1995"],"issn-type":[{"value":"1735-1995","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}